Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
MVM Partners is a venture capital and private equity firm founded in 1997, specializing in high-growth healthcare and life sciences companies across medical technology, pharmaceuticals, diagnostics, digital health, and related sectors. With offices in Boston, London, and the San Francisco Bay Area
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is MVM Life Science Partners' primary investment focus?
- MVM Life Science Partners specializes in high-growth healthcare and life sciences companies, including medical technology, pharmaceuticals, diagnostics, and digital health.
- When was MVM Life Science Partners founded?
- MVM Life Science Partners was founded in 1997.
- Can you name a notable exit for MVM Life Science Partners?
- MVM Life Science Partners had a notable exit with Cheetah Medical, which was acquired by Baxter International for $230M in September 2019.
- Which portfolio companies has MVM Life Science Partners invested in multiple times?
- MVM Life Science Partners has made multiple investments in Cheetah Medical and OSSIO.
- What is the geographic presence of MVM Life Science Partners?
- MVM Life Science Partners has offices in Boston, London, and the San Francisco Bay Area (Menlo Park).
- Has MVM Life Science Partners acted as a lead investor in any of its portfolio companies?
- Yes, MVM Life Science Partners was a lead investor in BioProtect, investing $28,000,000.
- What is the most recent investment date for MVM Life Science Partners according to startupim data?
- The most recent investment by MVM Life Science Partners was in OSSIO in December 2024, with an amount of $27,600,000.
- What is the earliest investment date for MVM Life Science Partners according to startupim data?
- The earliest investment by MVM Life Science Partners was in Cheetah Medical in April 2010, with an amount of $20,000,000.